Janney Montgomery Scott’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,050
Closed -$1.97M 2812
2023
Q2
$1.97M Sell
50,050
-19,543
-28% -$690K 0.01% 1079
2023
Q1
$1.69M Buy
69,593
+19,543
+39% +$428K 0.01% 1050
2022
Q4
$1.07M Hold
50,050
﹤0.01% 1332
2022
Q3
$898K Hold
50,050
﹤0.01% 1365
2022
Q2
$477K Hold
50,050
﹤0.01% 1643
2022
Q1
$842K Hold
50,050
﹤0.01% 1350
2021
Q4
$837K Hold
50,050
﹤0.01% 1431
2021
Q3
$813K Hold
50,050
﹤0.01% 1383
2021
Q2
$316K Hold
50,050
﹤0.01% 1896
2021
Q1
$309K Buy
50,050
+50
+0.1% +$304 ﹤0.01% 1840
2020
Q4
$346K Buy
+50,000
New +$320K ﹤0.01% 1794

Janney Montgomery Scott's ISEE Position: Q3 2023 in Review

Janney Montgomery Scott sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 50,050 shares — an estimated $1.97M sold.

Janney Montgomery Scott first reported a position in ISEE in Q4 2020 and held it in 11 quarters. The position peaked at $1.97M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Janney Montgomery Scott reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 50,050 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.97M.
  • Janney Montgomery Scott first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Janney Montgomery Scott's IVERIC bio, Inc. Common Stock position peaked at $1.97M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Janney Montgomery Scott's 13F filing for Q3 2023, filed 8 Nov 2023.